过导管方法对心房功能性 mitra 反:我们已经走了多远?
Alberto Preda1, Francesca Coppi2, Francesco Melillo3,4
1De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy.
概括
在老年患者中,越来越多地观察到心房功能性脑膜反 (aFMR),心房动 (AF) 和心力衰竭与保留射出小部分 (HFpEF). 本综述更新了aFMR的诊断和透导管治疗方法,包括边缘到边缘的修复.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 电子生理学 电子生理学
背景情况:
- 在老年患者中,越来越多地诊断出心房功能性腹 (aFMR),特别是那些心房动 (AF) 和心力衰竭与保留射出分数 (HFpEF) 的老年患者.
- 病理生理学涉及环状扩大,改变的环状收缩和心房发育的叶片结合,与心室起源不同.
- 在诊断和管理方面缺乏共识带来了挑战.
研究的目的:
- 提供关于aFMR的诊断和治疗的最新概述.
- 专注于用于FMR管理的跨导管方法.
- 突出了AF患者的节律控制策略.
主要方法:
- 对aFMR诊断和管理的当前文献的综述.
- 讨论过导管中枢的修复技术 (边缘修复,无效整形,更换).
- 探索导管切除和混合策略用于AF节律控制.
主要成果:
- 透导管中枢的修复显示了乐观的短期到中期结果.
- 通过导管切除来控制AF的节奏,可以促进反向重塑和改善叶片共.
- 混合废除策略可以改善持续性AF的无心律生存率.
结论:
- aFMR的诊断和管理需要量身定制的策略.
- 过导管干预为aFMR提供了有前途的治疗选择.
- 结合门修复和AF节律控制的综合方法对于最佳的患者结果至关重要.
相关概念视频
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


